Acid-sensing ion channels: Linking extracellular acidification with atherosclerosis

•The influence of acidity on atherogenesis is illustrated.•The potential pro-atherosclerosis of acid-sensing ion channels is proposed.•Acid-sensing ion channels mediate the influence of acidity on atherogenesis. Extracellular acidification in atherosclerosis-prone regions of arterial walls is consid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2020-03, Vol.502, p.183-190
Hauptverfasser: Zhang, Rong-Jie, Yin, Yu-Fang, Xie, Xue-Jiao, Gu, Hong-Feng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•The influence of acidity on atherogenesis is illustrated.•The potential pro-atherosclerosis of acid-sensing ion channels is proposed.•Acid-sensing ion channels mediate the influence of acidity on atherogenesis. Extracellular acidification in atherosclerosis-prone regions of arterial walls is considered pro-atherosclerotic by exerting detrimental effect on macrophages, endothelial cells (ECs) and vascular smooth muscle cells (VSMCs). Acid-sensing ion channels (ASICs), a family of extracellular H+ (proton)-gated cation channels, are present extensively in the nervous system and other tissues, implying physiologic as well as pathophysiologic importance. Aberrant activation of ASICs is thought to be associated in EC dysfunction, macrophage phenotypic switch, and VSMC migration and proliferation. Although in vitro evidence acknowledges the contribution of ASIC activation in atherosclerosis, no direct evidence confirms their pro-atherosclerotic roles in vivo. In this review, the effect of extracellular acidity on three major contributors, ECs, macrophages, and VSMCs, is discussed focusing on the potential roles of ASICs in atherosclerotic development and underlying pathology. A more comprehensive understanding of ASICs in these processes may provide promising new therapeutic targets for treatment and prevention of atherosclerotic diseases.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2019.12.027